Denmark will not use the Johnson & Johnson vaccine, the Danish Overall health Authority announced on Monday, saying in a statement that the nation could make ample progress making use of other vaccines and did not have to have to run the chance of a unusual, unsafe blood clotting affliction that might be linked to the Johnson & Johnson vaccine.
The nation has halted administering the AstraZeneca vaccine for related factors, just after two people today died of blood clots just after currently being provided that vaccine.
Denmark had been setting up to use the Johnson & Johnson single-dose vaccine in advance of reviews emerged about a probable website link to the clotting affliction, which looks to largely influence younger gals. Dropping the vaccine from its ideas will set back the country’s timetable for vaccinating grownups below forty by about a month, Danish officials explained.
The United States temporarily suspended making use of the Johnson & Johnson vaccine, but the Meals and Drug Administration announced on Friday that it would be created obtainable once more, with a warning about the probable clotting chance extra to its label.
The European Medicines Company, the regulatory physique for the European Union, has also endorsed use of the Johnson & Johnson vaccine with an extra warning.
The Danish Overall health Authority, nevertheless, explained it had independently investigated the vaccine and determined towards making use of it.
“Taking the existing problem in Denmark into account, what we are at present shedding in our work to avoid serious sickness from Covid-19 can not outweigh the chance of creating probable side results in the type of serious blood clots in people we vaccinate,” the authority explained in a statement.
“One must also bear in thoughts that, going forward, we will to start with and foremost be vaccinating younger and healthier people today,” Helene Probst, the deputy director common of the authority, explained in the statement.
Christina Anderson contributed reporting.